Offer - Urjas Oil for just ₹ 1 X
Rancv 500 Tablet ER is a prescription medicine that is available as a Tablet. Angina are some of its major therapeutic uses.
The optimal dosage of Rancv 500 Tablet ER is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Rancv 500 Tablet ER have been listed ahead. Usually, these side effects of Rancv 500 Tablet ER go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Rancv 500 Tablet ER has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Rancv 500 Tablet ER's effects on the liver, heart and kidney, if any, have been listed below.
Rancv 500 Tablet ER is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions. Some other conditions that can be affected by Rancv 500 Tablet ER are listed in the contraindications section below.
Drug interactions for Rancv 500 Tablet ER have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Rancv 500 Tablet ER, it is important to know that it is not safe while driving, and is not habit-forming.
Rancv 500 Tablet ER is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rancv 500 Tablet ER safe for pregnant women?
Pregnant women may get severe side effects after taking Rancv. If you are pregnant, do not take Rancv without a doctor's advice.
Is the use of Rancv 500 Tablet ER safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Rancv. So it is adviced to consult the doctor before using it.
What is the effect of Rancv 500 Tablet ER on the Kidneys?
Rancv rarely affects the kidneys.
What is the effect of Rancv 500 Tablet ER on the Liver?
Rancv may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rancv 500 Tablet ER on the Heart?
Rancv has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Rancv 500 Tablet ER unless your doctor advises you to do so -
Is this Rancv 500 Tablet ER habit forming or addictive?
Rancv 500 Tablet ER is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rancv 500 Tablet ER, you should not drive or work on any heavy machine, as Rancv 500 Tablet ER can make you drowsy.
Is it safe?
Rancv 500 Tablet ER is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Rancv 500 Tablet ER cannot treat any kind of mental disorder.
Interaction between Food and Rancv 500 Tablet ER
Some foods when eaten with Rancv 500 Tablet ER can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Rancv 500 Tablet ER
No research has been done on this till date. Therefore, it is not known what the effect of taking Rancv 500 Tablet ER with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ranexa (ranolazine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 554
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1084-1085